Nature Publishing Group, publisher of Nature, and other science journals and reference works NATURE.COM NATURE NEWS NATUREJOBS NATUREEVENTS ABOUT NPG
Help Nature.com site index  
Journal of Human Hypertension
SEARCH     advanced search my account e-alerts subscribe register
Journal home
Advance online publication
Current issue
Archive
Press releases
For authors
For referees
Contact editorial office
About the journal
For librarians
Subscribe
Advertising
naturereprints
Contact NPG
Customer services
Site features
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 
July 1999, Volume 13, Number 7, Pages 473-476
Table of contents    Previous  Abstract  Next   Article  PDF
Original article
Comparison between isosorbide dinitrate aerosol and nifedipine in the treatment of hypertensive emergencies
A F Rubio-Guerra, G Vargas-Ayala, J J Lozano-Nuevo, J L Narvaez-Rivera and L Rodriguez-Lopez

Department of Internal Medicine, Ticoman General Hospital, Institute of Health of Mexico D.F.

Correspondence to: Alberto Francisco Rubio-Guerra, Alberto Francisco Rubio-Guerra, Ticoman General Hospital, Plan de San Luis S/N Esq Bandera, Mexico D.F. C.P.07330

Abstract

Background: Nitric oxide donors have been used in the management of hypertensive emergencies (HE). Isosorbide dinitrate aerosol (ISA) is a nitric oxide fast-acting donor. The aim of this study is to compare the efficacy of ISA and nifedipine in the treatment of HE.Methods: Sixty adult patients with an HE were randomised to receive either ISA (2.5 mg) or nifedipine (10 mg). Patients were given an electrocardiogram (ECG) immediately prior, and 30 min after administering the medication. Blood pressure (BP) was measured every 5 min for the first 30 min, and then every 30 min for a period of 6 h.Results: Blood pressure values for all patients in the ISA group decreased significantly (187 ± 13/121 ± 6 to 153 ± 15/92.3 ± 7.6 mm Hg, P < 0.005). two of the patients in this group had angor pectoris with evidence of subepicardial ischaemia as seen in the first ecg, both of which disappeared with the drug. heart rate decreased by 14% similarly, all patients in the nifedipine group had significant decreases in bp (190 ± 23/115 ± 7 to 153 ± 26/86 ± 6 mm hg, P < 0.005). their first ecg was normal. two patients suffered angor pectoris after nifedipine, with subepicardial ischaemia registering in the second ecg. heart rate increased 11.9&percnt in this group. during the follow-up period, no clinically significant side effects or cases of rebound hypertension were observed in the isa group, whereas in the nifedipine group, eight patients reported having headaches and four others rebound hypertension.Conclusion: Our results show a favourable effect of ISA in the treatment of HE.

Keywords

nifedipine; isosorbide dinitrate aerosol; tolerability; hypertensive emergencies

Received 5 August 1998; revised 26 February 1999; accepted 17 March 1999
July 1999, Volume 13, Number 7, Pages 473-476
Table of contents    Previous  Abstract  Next   Article  PDF
Privacy Policy © 1999 Nature Publishing Group